Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 1763-1768, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fingerhut, R.
Right arrow Articles by Roscher, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fingerhut, R.
Right arrow Articles by Roscher, A. A.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2001;47:1763-1768.)
© 2001 American Association for Clinical Chemistry, Inc.

Articles

Hepatic Carnitine Palmitoyltransferase I Deficiency: Acylcarnitine Profiles in Blood Spots Are Highly Specific

Ralph Fingerhut1a, Wulf Röschinger2, Ania C. Muntau2, Torsten Dame1, Jens Kreischer1, Ralf Arnecke1, Andrea Superti-Furga3, Heinz Troxler3, Bernhard Liebl4, Bernhard Olgemöller1 and Adelbert A. Roscher2

1 Labor Becker, Olgemöller & Kollegen, D-81671 Munich, Germany.

2 Dr. von Hauner Children’s Hospital, Department of Clinical Chemistry and Biochemical Genetics, Ludwig-Maximilians-University, D-80337 Munich, Germany.

3 University Children’s Hospital, CH-8032 Zurich, Switzerland.

4 Public Health Screening Center, D-80764 Oberschleissheim, Germany.

aAddress correspondence to this author at: Labor Becker, Olgemöller & Kollegen, Führichstrasse 70, D-81671 Munich, Germany. Fax 49-89-544-654-10; e-mail fingerhu{at}labor-bo.de.

Background: In carnitine palmitoyltransferase I (CPT-I) deficiency (MIM 255120), free carnitine can be increased with no pathologic acylcarnitine species detectable. As inclusion of CPT-I deficiency in high-risk and newborn screening could prevent potentially life-threatening complications, we tested whether CPT-I deficiency might be diagnosed by electrospray ionization-tandem mass spectrometry (ESI-MS/MS).

Methods: A 3.2-mm spot of whole blood dried on filter paper was extracted with 150 µL of methanol. After derivatization of carnitine and acylcarnitines to their butyl esters, the samples were analyzed by ESI-MS/MS with 37.5 pmol of L-[2H3]carnitine and 7.5 pmol of L-[2H3]palmitoylcarnitine as internal standards.

Results: In all dried-blood specimens from each of three patients with CPT-I deficiency, we found an invariably increased ratio of free carnitine to the sum of palmitoylcarnitine and stearoylcarnitine [C0/(C16 + C18)]. The ratio in patients was between 175 and 2000, or 5- to 60-fold higher than the ratio for the 99.9th centile of the normal newborn population in Bavaria (n = 177 842). No overlap with the values of children that were known to be supplemented with carnitine was detected [C0/(C16 + C18), 34 ± 30; mean ± SD; n = 27].

Conclusions: ESI-MS/MS provides a highly specific acylcarnitine profile from dried-blood samples. The ratio of free carnitine to the sum of palmitoylcarnitine and stearoylcarnitine [C0/(C16 + C18)] is highly specific for CPT-I deficiency and may allow presymptomatic diagnosis.




The following articles in journals at HighWire Press have cited this article:


Home page
 PediatricsHome page
B. A. Tarini, D. A. Christakis, and H. G. Welch
State Newborn Screening in the Tandem Mass Spectrometry Era: More Tests, More False-Positive Results
Pediatrics, August 1, 2006; 118(2): 448 - 456.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
F. Lehner, H. Demmelmair, W. Roschinger, T. Decsi, M. Szasz, K. Adamovich, R. Arnecke, and B. Koletzko
Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants
J. Lipid Res., February 1, 2006; 47(2): 404 - 411.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. H. Chace, T. A. Kalas, and E. W. Naylor
Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
Clin. Chem., November 1, 2003; 49(11): 1797 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. Schulze, M. Lindner, D. Kohlmuller, K. Olgemoller, E. Mayatepek, and G. F. Hoffmann
Expanded Newborn Screening for Inborn Errors of Metabolism by Electrospray Ionization-Tandem Mass Spectrometry: Results, Outcome, and Implications
Pediatrics, June 1, 2003; 111(6): 1399 - 1406.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.